PLRX · Pliant Therapeutics, Inc. · Proposed Sales
Market Cap
$56.50M
Shares
61.92M
Volume · Oct 20
319.69K
Avg daily vol (3M)
421.65K
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2025-01-22 | MICHAEL OUIMETTE | Officer | 10,230 | 2025-01-22 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2023-08-03 | JOHANNES P HULL | Officer | 34,919 | 2023-08-03 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2023-07-20 | MICHAEL OUIMETTE | Officer | 4,755 | 2023-07-20 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Showing 1–3 of 3 filings